Global Child cold medicine Market

Child cold medicine Comprehensive Study by Type (Cough Medicine, Cold Medicine, Flu Medicine), Infancy Age Group (1 Year to 6 Year, 6 Year to12 Year), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), Mode of Sales (Prescription medicine, Over the Counter (OTC)) Players and Region - Global Market Outlook to 2028

Child cold medicine Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Child cold medicines belong to the special category of medicines that are prescribed for the pediatric group of patients, in various indications. The FDA encourages drug manufacturers to offer a dosing instrument including a cup or syringe market with the correct measurements. The child cold medicines market is highly competitive due to the rise in the number of various growth strategies such as pricing strategies, robust R&D, and merger and acquisition strategies to increase their market share.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledNovartis (Switzerland), Pfizer Inc. (United States), Pharmaceutical Product Development (United States), Johnson and Johnson (United States), Genzyme Corporation (United States), Procter & Gamble (Vicks) (United States), Harbin Pharmaceutical Group Co., Ltd. (China), Renhe Group. (China), Eisai Co., Ltd. (Japan), Astellas Pharma Inc. (Japan), Teva Pharmaceutical Industries Limited (Israel), Daiichi Sankyo Company Limited (Japan), Shionogi & Company, Limited. (Japan) and Servier Laboratories (France)


This growth is primarily driven by Increasing Government Funding and Awareness Programs in Both Developed and Developing Nations and Rising Number of Short term Diseases Related to Respiratory or Ocular Infections.

Globally, a noticeable market trend is evident The Growth in Investment in R&D by Major Market Players Major Players, such as Novartis (Switzerland), Pfizer Inc. (United States), Pharmaceutical Product Development (United States), Johnson and Johnson (United States), Genzyme Corporation (United States), Procter & Gamble (Vicks) (United States), Harbin Pharmaceutical Group Co., Ltd. (China), Renhe Group. (China), Eisai Co., Ltd. (Japan), Astellas Pharma Inc. (Japan), Teva Pharmaceutical Industries Limited (Israel), Daiichi Sankyo Company Limited (Japan), Shionogi & Company, Limited. (Japan) and Servier Laboratories (France), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. Emphasizing the safety and reliability of products can be a powerful competitive strategy in the child cold medicine market. Manufacturers can conduct rigorous testing, ensure compliance with regulatory standards, and communicate the safety measures taken in the manufacturing process to build trust among parents and caregivers.

Key Developments in the Market:
In June 2022, Pfizer Inc. successfully completed the acquisition of ReViral, a privately held clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel antiviral therapeutics against the respiratory syncytial virus (RSV) announced as complete.

Regulatory Insights:
In the United States, Food and Drug Administration (FDA) is the regulatory authority that oversees the safety, efficacy, and labeling of pharmaceutical products, including medications for children. The FDA has specific guidelines and requirements for the development, testing, and approval of over-the-counter (OTC) medications for children, including cold medicines.

Influencing Trend:
The Growth in Investment in R&D by Major Market Players

Market Growth Drivers:
Increasing Government Funding and Awareness Programs in Both Developed and Developing Nations and Rising Number of Short term Diseases Related to Respiratory or Ocular Infections

Challenges:
Lack of Awareness in Rural Areas

Restraints:
Low Disposable Income in Underdeveloped Nations and Side Effects by Some Medicines

Opportunities:
Increasing Number of Pediatric Population in Developing Nations

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Child cold medicine Market
- Analysis about New Entrants in Child cold medicine Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Child cold medicine Study Sheds Light on
— The Child cold medicine Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Child cold medicine industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Child cold medicine industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Cough Medicine
  • Cold Medicine
  • Flu Medicine
By Infancy Age Group
  • 1 Year to 6 Year
  • 6 Year to12 Year

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacy
  • Other

By Mode of Sales
  • Prescription medicine
  • Over the Counter (OTC)

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Government Funding and Awareness Programs in Both Developed and Developing Nations
      • 3.2.2. Rising Number of Short term Diseases Related to Respiratory or Ocular Infections
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness in Rural Areas
    • 3.4. Market Trends
      • 3.4.1. The Growth in Investment in R&D by Major Market Players
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Child cold medicine, by Type, Infancy Age Group, Distribution Channel, Mode of Sales and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Child cold medicine (Value)
      • 5.2.1. Global Child cold medicine by: Type (Value)
        • 5.2.1.1. Cough Medicine
        • 5.2.1.2. Cold Medicine
        • 5.2.1.3. Flu Medicine
      • 5.2.2. Global Child cold medicine by: Infancy Age Group (Value)
        • 5.2.2.1. 1 Year to 6 Year
        • 5.2.2.2. 6 Year to12 Year
      • 5.2.3. Global Child cold medicine by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacy
        • 5.2.3.4. Other
      • 5.2.4. Global Child cold medicine by: Mode of Sales (Value)
        • 5.2.4.1. Prescription medicine
        • 5.2.4.2. Over the Counter (OTC)
      • 5.2.5. Global Child cold medicine Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Child cold medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pharmaceutical Product Development (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Johnson and Johnson (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Genzyme Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Procter & Gamble (Vicks) (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Harbin Pharmaceutical Group Co., Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Renhe Group. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eisai Co., Ltd. (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Astellas Pharma Inc. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Teva Pharmaceutical Industries Limited (Israel)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Daiichi Sankyo Company Limited (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Shionogi & Company, Limited. (Japan)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Servier Laboratories (France)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Child cold medicine Sale, by Type, Infancy Age Group, Distribution Channel, Mode of Sales and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Child cold medicine (Value)
      • 7.2.1. Global Child cold medicine by: Type (Value)
        • 7.2.1.1. Cough Medicine
        • 7.2.1.2. Cold Medicine
        • 7.2.1.3. Flu Medicine
      • 7.2.2. Global Child cold medicine by: Infancy Age Group (Value)
        • 7.2.2.1. 1 Year to 6 Year
        • 7.2.2.2. 6 Year to12 Year
      • 7.2.3. Global Child cold medicine by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacy
        • 7.2.3.4. Other
      • 7.2.4. Global Child cold medicine by: Mode of Sales (Value)
        • 7.2.4.1. Prescription medicine
        • 7.2.4.2. Over the Counter (OTC)
      • 7.2.5. Global Child cold medicine Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Child cold medicine: by Type(USD Million)
  • Table 2. Child cold medicine Cough Medicine , by Region USD Million (2017-2022)
  • Table 3. Child cold medicine Cold Medicine , by Region USD Million (2017-2022)
  • Table 4. Child cold medicine Flu Medicine , by Region USD Million (2017-2022)
  • Table 5. Child cold medicine: by Infancy Age Group(USD Million)
  • Table 6. Child cold medicine 1 Year to 6 Year , by Region USD Million (2017-2022)
  • Table 7. Child cold medicine 6 Year to12 Year , by Region USD Million (2017-2022)
  • Table 8. Child cold medicine: by Distribution Channel(USD Million)
  • Table 9. Child cold medicine Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 10. Child cold medicine Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 11. Child cold medicine Online Pharmacy , by Region USD Million (2017-2022)
  • Table 12. Child cold medicine Other , by Region USD Million (2017-2022)
  • Table 13. Child cold medicine: by Mode of Sales(USD Million)
  • Table 14. Child cold medicine Prescription medicine , by Region USD Million (2017-2022)
  • Table 15. Child cold medicine Over the Counter (OTC) , by Region USD Million (2017-2022)
  • Table 16. South America Child cold medicine, by Country USD Million (2017-2022)
  • Table 17. South America Child cold medicine, by Type USD Million (2017-2022)
  • Table 18. South America Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 19. South America Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 20. South America Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 21. Brazil Child cold medicine, by Type USD Million (2017-2022)
  • Table 22. Brazil Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 23. Brazil Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 24. Brazil Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 25. Argentina Child cold medicine, by Type USD Million (2017-2022)
  • Table 26. Argentina Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 27. Argentina Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 28. Argentina Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 29. Rest of South America Child cold medicine, by Type USD Million (2017-2022)
  • Table 30. Rest of South America Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 31. Rest of South America Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 32. Rest of South America Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 33. Asia Pacific Child cold medicine, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Child cold medicine, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 36. Asia Pacific Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 37. Asia Pacific Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 38. China Child cold medicine, by Type USD Million (2017-2022)
  • Table 39. China Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 40. China Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 41. China Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 42. Japan Child cold medicine, by Type USD Million (2017-2022)
  • Table 43. Japan Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 44. Japan Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 45. Japan Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 46. India Child cold medicine, by Type USD Million (2017-2022)
  • Table 47. India Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 48. India Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 49. India Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 50. South Korea Child cold medicine, by Type USD Million (2017-2022)
  • Table 51. South Korea Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 52. South Korea Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 53. South Korea Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 54. Taiwan Child cold medicine, by Type USD Million (2017-2022)
  • Table 55. Taiwan Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 56. Taiwan Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 57. Taiwan Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 58. Australia Child cold medicine, by Type USD Million (2017-2022)
  • Table 59. Australia Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 60. Australia Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 61. Australia Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Child cold medicine, by Type USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 66. Europe Child cold medicine, by Country USD Million (2017-2022)
  • Table 67. Europe Child cold medicine, by Type USD Million (2017-2022)
  • Table 68. Europe Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 69. Europe Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 70. Europe Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 71. Germany Child cold medicine, by Type USD Million (2017-2022)
  • Table 72. Germany Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 73. Germany Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 74. Germany Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 75. France Child cold medicine, by Type USD Million (2017-2022)
  • Table 76. France Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 77. France Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 78. France Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 79. Italy Child cold medicine, by Type USD Million (2017-2022)
  • Table 80. Italy Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 81. Italy Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 82. Italy Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 83. United Kingdom Child cold medicine, by Type USD Million (2017-2022)
  • Table 84. United Kingdom Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 85. United Kingdom Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 86. United Kingdom Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 87. Netherlands Child cold medicine, by Type USD Million (2017-2022)
  • Table 88. Netherlands Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 89. Netherlands Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 90. Netherlands Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 91. Rest of Europe Child cold medicine, by Type USD Million (2017-2022)
  • Table 92. Rest of Europe Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 93. Rest of Europe Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 94. Rest of Europe Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 95. MEA Child cold medicine, by Country USD Million (2017-2022)
  • Table 96. MEA Child cold medicine, by Type USD Million (2017-2022)
  • Table 97. MEA Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 98. MEA Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 99. MEA Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 100. Middle East Child cold medicine, by Type USD Million (2017-2022)
  • Table 101. Middle East Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 102. Middle East Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 103. Middle East Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 104. Africa Child cold medicine, by Type USD Million (2017-2022)
  • Table 105. Africa Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 106. Africa Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 107. Africa Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 108. North America Child cold medicine, by Country USD Million (2017-2022)
  • Table 109. North America Child cold medicine, by Type USD Million (2017-2022)
  • Table 110. North America Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 111. North America Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 112. North America Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 113. United States Child cold medicine, by Type USD Million (2017-2022)
  • Table 114. United States Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 115. United States Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 116. United States Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 117. Canada Child cold medicine, by Type USD Million (2017-2022)
  • Table 118. Canada Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 119. Canada Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 120. Canada Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 121. Mexico Child cold medicine, by Type USD Million (2017-2022)
  • Table 122. Mexico Child cold medicine, by Infancy Age Group USD Million (2017-2022)
  • Table 123. Mexico Child cold medicine, by Distribution Channel USD Million (2017-2022)
  • Table 124. Mexico Child cold medicine, by Mode of Sales USD Million (2017-2022)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Child cold medicine: by Type(USD Million)
  • Table 140. Child cold medicine Cough Medicine , by Region USD Million (2023-2028)
  • Table 141. Child cold medicine Cold Medicine , by Region USD Million (2023-2028)
  • Table 142. Child cold medicine Flu Medicine , by Region USD Million (2023-2028)
  • Table 143. Child cold medicine: by Infancy Age Group(USD Million)
  • Table 144. Child cold medicine 1 Year to 6 Year , by Region USD Million (2023-2028)
  • Table 145. Child cold medicine 6 Year to12 Year , by Region USD Million (2023-2028)
  • Table 146. Child cold medicine: by Distribution Channel(USD Million)
  • Table 147. Child cold medicine Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 148. Child cold medicine Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 149. Child cold medicine Online Pharmacy , by Region USD Million (2023-2028)
  • Table 150. Child cold medicine Other , by Region USD Million (2023-2028)
  • Table 151. Child cold medicine: by Mode of Sales(USD Million)
  • Table 152. Child cold medicine Prescription medicine , by Region USD Million (2023-2028)
  • Table 153. Child cold medicine Over the Counter (OTC) , by Region USD Million (2023-2028)
  • Table 154. South America Child cold medicine, by Country USD Million (2023-2028)
  • Table 155. South America Child cold medicine, by Type USD Million (2023-2028)
  • Table 156. South America Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 157. South America Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 158. South America Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 159. Brazil Child cold medicine, by Type USD Million (2023-2028)
  • Table 160. Brazil Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 161. Brazil Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 162. Brazil Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 163. Argentina Child cold medicine, by Type USD Million (2023-2028)
  • Table 164. Argentina Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 165. Argentina Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 166. Argentina Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 167. Rest of South America Child cold medicine, by Type USD Million (2023-2028)
  • Table 168. Rest of South America Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 169. Rest of South America Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 170. Rest of South America Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 171. Asia Pacific Child cold medicine, by Country USD Million (2023-2028)
  • Table 172. Asia Pacific Child cold medicine, by Type USD Million (2023-2028)
  • Table 173. Asia Pacific Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 174. Asia Pacific Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 175. Asia Pacific Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 176. China Child cold medicine, by Type USD Million (2023-2028)
  • Table 177. China Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 178. China Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 179. China Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 180. Japan Child cold medicine, by Type USD Million (2023-2028)
  • Table 181. Japan Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 182. Japan Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 183. Japan Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 184. India Child cold medicine, by Type USD Million (2023-2028)
  • Table 185. India Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 186. India Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 187. India Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 188. South Korea Child cold medicine, by Type USD Million (2023-2028)
  • Table 189. South Korea Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 190. South Korea Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 191. South Korea Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 192. Taiwan Child cold medicine, by Type USD Million (2023-2028)
  • Table 193. Taiwan Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 194. Taiwan Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 195. Taiwan Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 196. Australia Child cold medicine, by Type USD Million (2023-2028)
  • Table 197. Australia Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 198. Australia Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 199. Australia Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 200. Rest of Asia-Pacific Child cold medicine, by Type USD Million (2023-2028)
  • Table 201. Rest of Asia-Pacific Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 202. Rest of Asia-Pacific Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 203. Rest of Asia-Pacific Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 204. Europe Child cold medicine, by Country USD Million (2023-2028)
  • Table 205. Europe Child cold medicine, by Type USD Million (2023-2028)
  • Table 206. Europe Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 207. Europe Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 208. Europe Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 209. Germany Child cold medicine, by Type USD Million (2023-2028)
  • Table 210. Germany Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 211. Germany Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 212. Germany Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 213. France Child cold medicine, by Type USD Million (2023-2028)
  • Table 214. France Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 215. France Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 216. France Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 217. Italy Child cold medicine, by Type USD Million (2023-2028)
  • Table 218. Italy Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 219. Italy Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 220. Italy Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 221. United Kingdom Child cold medicine, by Type USD Million (2023-2028)
  • Table 222. United Kingdom Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 223. United Kingdom Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 224. United Kingdom Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 225. Netherlands Child cold medicine, by Type USD Million (2023-2028)
  • Table 226. Netherlands Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 227. Netherlands Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 228. Netherlands Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 229. Rest of Europe Child cold medicine, by Type USD Million (2023-2028)
  • Table 230. Rest of Europe Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 231. Rest of Europe Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 232. Rest of Europe Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 233. MEA Child cold medicine, by Country USD Million (2023-2028)
  • Table 234. MEA Child cold medicine, by Type USD Million (2023-2028)
  • Table 235. MEA Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 236. MEA Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 237. MEA Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 238. Middle East Child cold medicine, by Type USD Million (2023-2028)
  • Table 239. Middle East Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 240. Middle East Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 241. Middle East Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 242. Africa Child cold medicine, by Type USD Million (2023-2028)
  • Table 243. Africa Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 244. Africa Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 245. Africa Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 246. North America Child cold medicine, by Country USD Million (2023-2028)
  • Table 247. North America Child cold medicine, by Type USD Million (2023-2028)
  • Table 248. North America Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 249. North America Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 250. North America Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 251. United States Child cold medicine, by Type USD Million (2023-2028)
  • Table 252. United States Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 253. United States Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 254. United States Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 255. Canada Child cold medicine, by Type USD Million (2023-2028)
  • Table 256. Canada Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 257. Canada Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 258. Canada Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 259. Mexico Child cold medicine, by Type USD Million (2023-2028)
  • Table 260. Mexico Child cold medicine, by Infancy Age Group USD Million (2023-2028)
  • Table 261. Mexico Child cold medicine, by Distribution Channel USD Million (2023-2028)
  • Table 262. Mexico Child cold medicine, by Mode of Sales USD Million (2023-2028)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Child cold medicine: by Type USD Million (2017-2022)
  • Figure 5. Global Child cold medicine: by Infancy Age Group USD Million (2017-2022)
  • Figure 6. Global Child cold medicine: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global Child cold medicine: by Mode of Sales USD Million (2017-2022)
  • Figure 8. South America Child cold medicine Share (%), by Country
  • Figure 9. Asia Pacific Child cold medicine Share (%), by Country
  • Figure 10. Europe Child cold medicine Share (%), by Country
  • Figure 11. MEA Child cold medicine Share (%), by Country
  • Figure 12. North America Child cold medicine Share (%), by Country
  • Figure 13. Global Child cold medicine share by Players 2022 (%)
  • Figure 14. Global Child cold medicine share by Players (Top 3) 2022(%)
  • Figure 15. Global Child cold medicine share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Novartis (Switzerland) Revenue: by Geography 2022
  • Figure 19. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pfizer Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Pharmaceutical Product Development (United States) Revenue, Net Income and Gross profit
  • Figure 22. Pharmaceutical Product Development (United States) Revenue: by Geography 2022
  • Figure 23. Johnson and Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 24. Johnson and Johnson (United States) Revenue: by Geography 2022
  • Figure 25. Genzyme Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Genzyme Corporation (United States) Revenue: by Geography 2022
  • Figure 27. Procter & Gamble (Vicks) (United States) Revenue, Net Income and Gross profit
  • Figure 28. Procter & Gamble (Vicks) (United States) Revenue: by Geography 2022
  • Figure 29. Harbin Pharmaceutical Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 30. Harbin Pharmaceutical Group Co., Ltd. (China) Revenue: by Geography 2022
  • Figure 31. Renhe Group. (China) Revenue, Net Income and Gross profit
  • Figure 32. Renhe Group. (China) Revenue: by Geography 2022
  • Figure 33. Eisai Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Eisai Co., Ltd. (Japan) Revenue: by Geography 2022
  • Figure 35. Astellas Pharma Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Astellas Pharma Inc. (Japan) Revenue: by Geography 2022
  • Figure 37. Teva Pharmaceutical Industries Limited (Israel) Revenue, Net Income and Gross profit
  • Figure 38. Teva Pharmaceutical Industries Limited (Israel) Revenue: by Geography 2022
  • Figure 39. Daiichi Sankyo Company Limited (Japan) Revenue, Net Income and Gross profit
  • Figure 40. Daiichi Sankyo Company Limited (Japan) Revenue: by Geography 2022
  • Figure 41. Shionogi & Company, Limited. (Japan) Revenue, Net Income and Gross profit
  • Figure 42. Shionogi & Company, Limited. (Japan) Revenue: by Geography 2022
  • Figure 43. Servier Laboratories (France) Revenue, Net Income and Gross profit
  • Figure 44. Servier Laboratories (France) Revenue: by Geography 2022
  • Figure 45. Global Child cold medicine: by Type USD Million (2023-2028)
  • Figure 46. Global Child cold medicine: by Infancy Age Group USD Million (2023-2028)
  • Figure 47. Global Child cold medicine: by Distribution Channel USD Million (2023-2028)
  • Figure 48. Global Child cold medicine: by Mode of Sales USD Million (2023-2028)
  • Figure 49. South America Child cold medicine Share (%), by Country
  • Figure 50. Asia Pacific Child cold medicine Share (%), by Country
  • Figure 51. Europe Child cold medicine Share (%), by Country
  • Figure 52. MEA Child cold medicine Share (%), by Country
  • Figure 53. North America Child cold medicine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Novartis (Switzerland)
  • Pfizer Inc. (United States)
  • Pharmaceutical Product Development (United States)
  • Johnson and Johnson (United States)
  • Genzyme Corporation (United States)
  • Procter & Gamble (Vicks) (United States)
  • Harbin Pharmaceutical Group Co., Ltd. (China)
  • Renhe Group. (China)
  • Eisai Co., Ltd. (Japan)
  • Astellas Pharma Inc. (Japan)
  • Teva Pharmaceutical Industries Limited (Israel)
  • Daiichi Sankyo Company Limited (Japan)
  • Shionogi & Company, Limited. (Japan)
  • Servier Laboratories (France)
Select User Access Type

Key Highlights of Report


May 2023 213 Pages 64 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Child cold medicine Market Quantitative research analysis
Global Child cold medicine Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Child cold medicine market are Novartis (Switzerland), Pfizer Inc. (United States), Pharmaceutical Product Development (United States), Johnson and Johnson (United States), Genzyme Corporation (United States), Procter & Gamble (Vicks) (United States), Harbin Pharmaceutical Group Co., Ltd. (China), Renhe Group. (China), Eisai Co., Ltd. (Japan), Astellas Pharma Inc. (Japan), Teva Pharmaceutical Industries Limited (Israel), Daiichi Sankyo Company Limited (Japan), Shionogi & Company, Limited. (Japan) and Servier Laboratories (France), to name a few.
is dominating the Child cold medicine Market.
"Lack of Awareness in Rural Areas" is seen as one of the major challenges by many Industry Players of Child cold medicine Market
The Child cold medicine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Child cold medicine market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Child cold medicine Market Report?

Have a Query? Click Here

Other Related Reports

Thrombosis Drug Comprehensive Study by Type (P2Y12 Platelet Inhibitor, Factor Xa Inhibitor, Heparin), Application (Deep Vein Thrombosis, Pulmonary Embolism, Atrial Fibrillation), Distribution Channel...
$ 3450
Allergen Extract Comprehensive Study by Type (Injectable Allergen Extracts (Standardized and Non-Standardized), Oral Allergen Extracts), Application (Hospital, Clinic) Players and Region - Global Mar...
$ 3500
Oncology Pharmaceuticals Comprehensive Study by Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), Application (Breast Cancer, Blood Cancer, Colorectal, Melanoma, Others)...
$ 3650
In-Vitro Toxicity Testing Comprehensive Study by Type (Absorption, Toxic Substances, Dose), Application (Systemic Toxicology, Dermal Toxicity, Endorine Disruption, Occular Toxicity, Others), Technolo...
$ 3750
Methyltestosterone Comprehensive Study by Type (Capsules, Tablets, Powder), Application (Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others}, Non-Medical), End Users...
$ 3500
Polycystic Ovary Syndrome (PCOS) Drugs Comprehensive Study by Application (Irregular periods, Excess androgen, Polycystic ovaries), Causes (Excess insulin, Low-grade inflammation, Heredity, Excess an...
$ 3350